Oxcarbazepine does not suppress cortical spreading depression

Cephalalgia

Volumn 31, Issue 5, 2011, Pages 537-542

  Hoffmann, Ulrike ^a   Dileköz, Ergin ^a,b   Kudo, Chiho ^a,c   Ayata, Cenk ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GAZI UNIVERSITY   (Turkey)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Cortical spreading depression; migraine; oxcarbazepine; valproate

Indexed keywords

OXCARBAZEPINE; POTASSIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CHRONIC DRUG ADMINISTRATION; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TREATMENT FAILURE; ELECTROSTIMULATION; MALE; MIGRAINE; NONHUMAN; PREDICTIVE VALUE; PROPHYLAXIS; RAT; SINGLE DRUG DOSE; SPREADING CORTICAL DEPRESSION; TREATMENT DURATION;

ANIMALS; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; CORTICAL SPREADING DEPRESSION; ELECTRIC STIMULATION; MALE; MIGRAINE DISORDERS; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; VALPROIC ACID;

EID: 79953190070     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410388433     Document Type: Article

References (14)

1. Ayata C. Spreading depression: from serendipity to targeted therapy in migraine prophylaxis. Cephalalgia 2009 ; 29: 1095-1114.
2. Silberstein S., Saper J., Berenson F., Somogyi M., McCague K. and D'Souza J. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. Neurology 2008 ; 70: 548-555. (Pubitemid 351653380)
3. Ayata C., Jin H., Kudo C., Dalkara T. and Moskowitz MA Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006 ; 59: 652-661.
4. Akerman S. and Goadsby PJ Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport 2005 ; 16: 1383-1387. (Pubitemid 41225215)
5. Bradley DP, Smith MI, Netsiri C., et al. Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. Exp Neurol 2001 ; 172: 342-353. (Pubitemid 34075083)
6. Brandt C., Gastens AM, Sun M., Hausknecht M. and Loscher W. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 2006 ; 51: 789-804. (Pubitemid 44286933)
7. Loscher W. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse. J Pharmacol Exp Ther 1978 ; 204: 255-261. (Pubitemid 8290127)
8. Jang Y., Kim ES, Park SS, Lee J. and Moon DE The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg 2005 ; 101: 800-806. (Pubitemid 41208514)
9. Hainzl D., Parada A. and Soares-da-Silva P. Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 2001 ; 44: 197-206. (Pubitemid 32452229)
10. Matar KM, Nicholls PJ, Bawazir SA, al- Hassan MI and Tekle A. Effect of valproic acid on the pharmacokinetic profile of oxcarbazepine in the rat. Pharm Acta Helv 1999 ; 73: 247-250. (Pubitemid 29092753)
11. Tecoma ES Oxcarbazepine. Epilepsia 1999 ; 40 (Suppl 5): S37 - S46.
12. Ayala-Guerrero F., Mexicano G., Campos-Sepulveda E., Romero RM, Reynoso-Robles R. and Gonzalez-Maciel A. Effect of oxcarbazepine pretreatment on convulsive activity and brain damage induced by kainic acid administration in rats. Comp Biochem Physiol A Mol Integr Physiol 2008 ; 151: 471-476.
13. Fox A., Gentry C., Patel S., Kesingland A. and Bevan S. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain 2003 ; 105: 355-362. (Pubitemid 37162506)
14. Wamil AW, Schmutz M., Portet C., Feldmann KF and McLean MJ Effects of oxcarbazepine and 10-hydroxy-carbamazepine on action potential firing and generalized seizures. Eur J Pharmacol 1994 ; 271: 301-308.